Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cerus Corp (CERS)

7.035   -0.065 (-0.92%) 08-07 14:39
Open: 7.22 Pre. Close: 7.1
High: 7.23 Low: 6.995
Volume: 787,515 Market Cap: 1,154M
Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma that is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; and INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.253 - 7.302 7.302 - 7.342
Low: 6.819 - 6.865 6.865 - 6.904
Close: 7.031 - 7.107 7.107 - 7.171

Technical analysis

as of: 2020-08-07 2:24:55 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 8.83     One year: 10.31
Support: Support1: 6.83    Support2: 6.38
Resistance: Resistance1: 7.56    Resistance2: 8.83
Pivot: 6.98
Moving Average: MA(5): 7.26     MA(20): 6.91
MA(100): 5.86     MA(250): 5.13
MACD: MACD(12,26): 0.17     Signal(9): 0.16
Stochastic oscillator: %K(14,3): 64.12     %D(3): 76.43
RSI: RSI(14): 53.63
52-week: High: 7.56  Low: 2.71  Change(%): 32.4
Average Vol(K): 3-Month: 193609  10-Days: 166172

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CERS has closed below upper band by 45.4%. Bollinger Bands are 22.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 07 Aug 2020
Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch - Business Wire

Fri, 07 Aug 2020
Cerus Corporation (NASDAQ: CERS) Plunges -2.47% And Its 4.68% Stock Volatility Is Bewildering - The Comet Reports

Wed, 05 Aug 2020
Cerus Corporation (CERS) Q2 2020 Earnings Call Transcript - Motley Fool

Tue, 04 Aug 2020
Cerus Corporation (CERS) CEO Obi Greenman on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Tue, 04 Aug 2020
Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Tue, 04 Aug 2020
Cerus Corporation (CERS) Breaks into New 52-Week High on August 04 Session -

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 164
Shares Float (M) 148
% Held by Insiders 2.12
% Held by Institutions 66.10
Shares Short (K) 10,490
Shares Short P. Month (K) 8,270

Stock Financials

EPS -0.480
EPS Est This Year -0.640
EPS Est Next Year -0.480
Book Value (p.s.) 0.690
Profit Margin -90.97
Operating Margin -86.54
Return on Assets (ttm) -20.9
Return on Equity (ttm) -75.8
Qtrly Rev. Growth 6.3
Gross Profit (p.s.) 0.251
Sales Per Share 0.462
EBITDA (p.s.) -0.383
Qtrly Earnings Growth
Operating Cash Flow (M) -63
Levered Free Cash Flow (M) -51

Stock Valuations

PE Ratio -14.65
PEG Ratio
Price to Book value 10.19
Price to Sales 15.22
Price to Cash Flow -18.17

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.